VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,711,000 | -15.1% | 967,859 | 0.0% | 0.19% | +12.0% |
| Q3 2017 | $17,325,000 | +9.8% | 967,859 | 0.0% | 0.17% | +0.6% |
| Q2 2017 | $15,776,000 | +2144.1% | 967,859 | +1828.0% | 0.16% | +1962.5% |
| Q1 2017 | $703,000 | -94.1% | 50,200 | -93.3% | 0.01% | -94.7% |
| Q4 2016 | $11,963,000 | -4.1% | 750,000 | 0.0% | 0.15% | +7.0% |
| Q3 2016 | $12,480,000 | +69.5% | 750,000 | +64.8% | 0.14% | +65.1% |
| Q2 2014 | $7,362,000 | -2.0% | 455,000 | -1.6% | 0.09% | -6.5% |
| Q1 2014 | $7,514,000 | -38.8% | 462,400 | -53.3% | 0.09% | -49.2% |
| Q4 2013 | $12,286,000 | +705.1% | 990,000 | +610.2% | 0.18% | +570.4% |
| Q3 2013 | $1,526,000 | – | 139,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |